PLOS
open access
CC BY 4.0
KSHV <i>K15</i> genetic heterogeneity is associated with Kaposi sarcoma aggressiveness through modulation of the host inflammatory microenvironment
Kaposi sarcoma (KS) exhibits profound clinical heterogeneity, yet current risk assessment remains constrained by anatomical staging systems that lack universality across diverse KS variants. This study characterized the functional impact of Kaposi’s sarcoma-associated herpesvirus (KSHV) K15 genotyp
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection#1172674
- Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS#858878
- Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma#1230869
- Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors#831159
- Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)#1032143
Record · ID 1237198
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive